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The backbone ‘H, “C and “N chemical shifts ofcyclophilin (CyP) when bound to cyclosporin A (CsA) have been assigned from heteronuclear 
two- and three-dimensional NMR experiments involving sclcctively “N- and uniformly 15N- and ‘SN,‘“C-labeled cyclophilin. From an analysis of 
the ‘H and 15N chemical shifts of CyP that change upon binding to CsA and from CyP/CsA NOES, we have determined the regions of cyclophilin 
involved in binding to CsA. 
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1. INTRODUCTION 
Human cyclophilin (CyP) from T lymphocytes is a 
protein of 165 amino acids and binds specifically to the 
immunosuppressive drug, cyclosporin A (CsA) [I ,2]. Se- 
veral pieces of evidence suggest hat the CyP/CsA com- 
plex is the biological effector involved in immunosup- 
pression, possibly by binding to and modulating the 
effects of a protein involved in T cell activation [3]. 
Indeed, it has recently been shown that the CyPICsA 
complex as well as another immunophilin/immunosup- 
pressant complex (FKBPIFK506) bind to and inhibit 
the calcium- and calmodulin-dependent phosphatase, 
calcineurin, which may play an important role in T cell 
and IgE receptor signaling pathways [4]. 
In order to understand the structural basis for the 
interaction between the immunophilins and immuno- 
suppressants as well as the common structural features 
that may be required for the binding of the immuno- 
philin/immunosuppressant complexes to other proteins, 
it is important to determine the three-dimensional struc- 
tures of the immunophilin/ligand complexes. A crystal 
structure of the FKBP/FK506 complex has been solved 
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[5] and solution structures of FKBP have appeared 
[6,7]. The conformation of CsA when bound to cyclo- 
philin has been determined [8,9], and very recently, an 
X-ray crystal structure of a tetrapeptide substrate 
bound to CyP [lo] as well as NMR studies of uncom- 
plexed CyP [ 1 l] and CyP bound to a water-soluble CsA 
derivative [lo] have been described. However, the com- 
plete three-dimensional structure of the CyP/CsA com- 
plex has not yet been reported. 
As a first step in determining the complete three- 
dimensional structure of the CyP/CsA complex by 
NMR, we have assigned the backbone ‘H, 13C and “N 
chemical shifts of cyclophilin when bound to CsA from 
heteronuclear two- and three-dimensional NMR experi- 
ments involving selectively “N- and uniformly “N- and 
‘5N,‘3C-labeled cyclophilin. From an analysis of the ‘H 
and “N chemical shifts of CyP that change upon bind- 
ing to CsA and from the identification of CyP/CsA 
NOES, we have identified those portions of CyP that 
bind CsA. 
2. MATERIALS AND METHODS 
2.1. Marerials 
Cloning of human cyclophilin and expression in E. coli was per- 
formed as previously described [12]. Competent E. coli strains AG-1 
were obtained from Stratagene and DL-39 [13] was obtained from the 
E. co/i Genetic Stock Center, Department of Biology, Yale University. 
All isotopically labeled amino acids were purchased from Cambridge 
Isotopes. The isotopically labeled cyclophilin samples were purified as 
previously described [12] from a prototrophic (AG-1) or polyauxs- 
trophic (DL-39) E. co/i strain [13] harboring the pBSl2 plasmid that 
overproduced human cyclophilin (-10 mg/l). For [U-“N]CyP and [U- 
“N,‘%]CyP, AG-1 cells were grown on minimal media containing 
[“N]NH,Cl and unlabeled or uniformly “C-labeled glucose (Martek 
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Fig. 1. H(0)0, 'H(co0 cross-sections corresponding to the 'SN frequencies (0)2) of M136-EI40 and I156-D160 of a 3D NOESY-HSQC spectrum 
of [U25N]CyP/CsA. NH/H ~ cross-peaks that were observed in a 3D TOCSY-HSQC spectrum of [U-'SN]CyP/CsA arc indicated by boxes. 
Corp.), respectively. [tSN-Lys]CyP and ['SN-Gly]CyP were obtained 
from AG-1 cells grown on a defined medium containing a mixture of 
unlabeled amino acids [14] and uniformly ~N-labeled Lys or tSN- 
labeled Gly, respectively. ['sN-Phe, '~C=O-Leu]CyP, ['SN-lle, '~C=O- 
Phe]CyP, [15N-Val, t3C=O-Ile]CyP, and ['SN-AIa]CyP were isolated 
from DL-39 containing pBSI2 grown on a defined medium [14] con- 
taining the appropriately abeled amino acid. 
2.2. NMR sample preparation 
The cyclophilin samples in phosphate buffer (50 mM, pH 6.5), 
containing NaCI (100 mM) and dithiothreitol (5 raM) in HzO were 
concentrated to -1.3 mM with a centricon YM-10 (Amicon). The CsA/ 
cyclophilin complexes were prepared [15] by gently shaking a suspen- 
sion of~1.5 mol equivalents of CsA in a solution of cyclophilin at 6°C 
for 12 h under argon. Uncomplexed CsA was removed by centrifuga- 
tion prior to NMR analysis. 
2.3. NMR experiments 
All NMR spectra were acquired on a Bruker AMX600 (600 MHz) 
NMR spectrometer at 20°C except for the 2D ~H-'H NOESY spec- 
trum which was acquired at 25°C on a Bruker AMX500 NMR spec- 
trometer. The spectra were processed using in-house written software 
on Silicon Graphics computers. 
The 2D 'H-~H NOESY spectrum was acquired on an unlabeled 
CyP/CsA complex dissolved in 2H20 using a sweep width of 7692.3 
Hz in to~ and 10 000 Hz in 0) 2. The data was collected as 320(t0 x 
2048(t2) complex points using 160 scans per increment and a mixing 
time of 100 ms. 
The 'H-~SN heteronuclear single quantum correlation (HSQC) spec- 
tra [16,17] were acquired using 2048 complex points in t 2 and 512 
complex points in h, with 96 scans per t, experiment. The sweep width 
was 10 000 Hz in 0) 2 CH) and 2890 Hz in 0)j ('SN). 
For the 'SN-resolved 3D NOESY-HSQC experiment [17 19] 256(h) 
x 25(t2) x 1024(t~) complex points were acquired using spectral widths 
of 9434 Hz (0),, ~H), 2890 Hz (0)2, ~SN), and 10 000 Hz (to> 'H). A 10 
ms homospoil pulse was applied uring the 50 ms NOESY mixing time 
and water suppression was accomplished with a 3 ms spinlock pulse 
using the method of W~thrich and coworkers [17]. 16 acquisitions 
were collected per t~,t2 experiment for a total experimental time of 
approximately 6 days. 
The 'SN-resolvcd 3D TOCSY-HSQC [20] spectrum was acquired 
with identical parameters except for 8 scans per h,t 2 experiment, 26 
complex points in 12 ('SN), and a 5 ms spinlock was used for water 
suppression. The TOCSY mixing time consisted of a 20 ms MLEV-17 
spinlock period (10 kHz) modified tbr the suppression of rotating 
frame NOE contributions [21]. 
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Fig. 2. C~(co~), NH(wd cross-sections corresponding to the 'SN frequencies (o)1) of MI36-E140 and T156-DI60 of a 3D HNCA (top) and 3D 
HN(CO)CA (bottom) spectrum of [U-'SN,'3C]CyP/CsA. N(i)/C~(i 1 )/NH(i) cross-peaks are indicated by boxes. For M 136, the N(i)/C=(i 1 )/NH(i) 
cross-peak to G135 is not present in this portion of the spectrum but was observed at 46.1 ppm. 
The 3D HNCA experiment [22] was acquired with 32 scans per t~,t 2
experiment with 42"80"1024 complex points and sweep widths of 
2890, 4717, and 10 000 Hz in (o1('5N), o)2(~3C), and o)3(~H), respec- 
tively. The delay for the evolution of the a~N-~C ~ coupling was set to 
22 ms to minimize relaxation losses. 
The 3D HN(CO)CA experiment [23] was acquired with 48 scans/ 
increment under identical sweep widths using 26"64"1024 complex 
points in o),(15N), co2(~3C) and (o3(~H), respectively. 
The 3D HNCO spectrum [22] was collected as 40"80"1024 complex 
points using sweep widths of 2890, 2273 and 10 000 Hz in co~('SN), 
o)2('3C') and o)3(~H), respectively. 16 scans were acquired per incre- 
ment for a total acquisition time of 3 days. For all of the triple 
resonance NMR experiments, water suppression was accomplished 
using a 3 ms spinlock pulse using the method of Wfithrich and co- 
workers [17]. 
3. RESULTS AND DISCUSSION 
The ~H, L3C and 'SN amide chemical shifts of CyP 
when bound to CsA were assigned from an analysis of 
five three-dimensional NMR spectra of [U-'SN]CyP/ 
CsA (3D NOESY-HSQC, 3D TOCSY-HSQC) and [U- 
15N,'3C]CyP/CsA (3D HNCA, 3D HN(CO)CA, 3D 
HNCO) and six two-dimensional HSQC spectra of se- 
lectively labeled CyP/CsA samples. Fig. 1 depicts IH,~H 
cross-sections (o)~,w3) of an 'slq-resolved 3D NOESY- 
HSQC spectrum of [U25N]CyP/CsA extracted at differ- 
ent 'SN amide frequencies (o)z). NOEs between CyP 
amide (o)3) and other protons appear along o),. The 
chemical shifts of the a-protons that are scalar coupled 
to the CyP amide protons were obtained in the comple- 
mentary 3D TOCSY-HSQC spectrum of [U-15N]CyP/ 
CsA extracted at the same 'SN amide chemical shifts, 
The a-protons identified in the 3D TOCSY-HSQC ex- 
periment are indicated by boxes in Fig. 1. From an 
analysis of these two 3D NMR spectra using a strategy 
that involves the matching of NOE cross-peaks [20,24], 
the amides of several adjacent amino acids of CyP were 
identified. For c~-helical regions of the protein, adjacent 
amino acids were identified from NH/NH and other 
characteristic NOEs [25] as illustrated in Fig. 1 for 
M136-E 140 of CyP. Ambiguities in the analysis of these 
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Fig. 3. IH, ~SN HSQC spectra (~H, horizontal axis; ~SN, vertical axis) 
of(A) [~SN-Phe]3C=O-Leu]CyP/CsA, (B) [~SN-Gly,Ser,Cys]CyP/CsA, 
(C) [UJSN]CyP/CsA, and (D) [U-L~N]CyP. The inset in (A) corre- 
sponds to a cross-section (vertical axis) of the amide ~I~t and ~SN 
frequency of F25. The cross-peaks marked by an 'x' in (A) and (B) 
were due to sample impurities as they were not observed in (C). CyP 
amide resonances in (C) that do not match any of the cross-peaks in 
(D) within the range of _+ 0.7 ppm for ~SN and/or _+ 0.17 ppm for ~H 
are labeled in (C). 
spectra rose for amide protons of adjacent amino acids 
that resonate at identical chemical shifts (e.g. M 136 and 
N 137). In principle, these ambiguities could be resolved 
from a 3D HMQC-NOE-HMQC experiment [26], or, as 
described below, from triple resonance 3D NMR ex- 
periments [22,23]. 
The amides of adjacent amino acids for the fl-sheet 
regions of CyP were identified from matching NOEs 
(primarily NH(i+I)/H~(i)) [25] as illustrated for I156- 
D160 of CyP (Fig. 1). In some cases, however, the anal- 
ysis was complicated by the overlap of s-protons, mis- 
sing cross-peaks in the TOCSY experiment, or the ob- 
servation of NOEs involving non-adjacent amino acids. 
The ambiguities encountered in the analysis of the 
two ~SN-resolved 3D NMR experiments were alleviated 
using two triple resonance 3D NMR experiments ap- 
plied to [UJSN,13C]CyP/CsA. In a 3D HNCA experi- 
ment (Fig. 2, top), the amide ~H (0 )3)  and ~SN (0)0 
chemical shifts of ith residue were correlated to the 
a-carbons (0)2) of the i and i 1 amino acids [22]. The 
Fig. 4. Secondary structure of the proposed CsA binding site as deter- 
mined from NOEs observed in a 3D HSQC-NOESY spectrum of 
[UJSN]CyP/CsA (solid arrows) and ]tI,~H NOESY spectrum (open- 
headed arrows) of CyP/CsA. NOEs observed in a ~3C 3D HMQC- 
NOESY spectrum of [UJ3C]CsA bound to CyP [9] are indicated by 
the dashed arrows. 
N(i)/C~(i-1)/NH(i) cross-peaks that could not be ob- 
served in the 3D HNCA spectrum (e.g. Fig. 2, A159, 
top), that overlapped with the N(i)/C~(i)/NH(i) cross- 
peaks (e.g. Fig. 2, T157, top), or that could not be 
unambiguously distinguished from the N(i)/C~(i)/NH(i) 
cross-peaks by their relative intensities (e.g. Fig. 1, I158, 
top) were identified in a 3D HN(CO)CA experiment. In
this spectrum the ~H (0)3) and ~SN (0)0chemical shifts 
of the amides (i) are correlated exclusively to the a- 
carbons (0)2) of the i-1 residues by magnetization trans- 
fer through the intervening carbonyl carbons [23], re- 
sulting in high sensitivity and an unambiguous distinc- 
tion between the C~(i) and C=(i--1) cross-peaks. 
As illustrated in Fig. 2, data obtained from these two 
triple resonance 3D NMR experiments complement the 
~SN-resolved 3D NMR data. For example, although the 
NH or a-protons overlap in the 3D NOESY-HSQC 
spectra, these ambiguities may be resolved in the triple 
resonance 3D NMR experiments (Fig. 2), since they rely 
on the identification of adjacent residues through the 
correlation of different chemical shifts (Ca). Other com- 
plications arising from the observation of NOEs be- 
tween non-adjacent amino acids could also be resolved 
in the triple resonance 3D NMR experiments, ince 
unlike the NOE experiment, the triple resonance experi- 
ments depend on throughbond couplings between the 
atoms of the peptide backbone. 
From an analysis of the four 3D NMR experiments, 
many strings of adjacent amino acids of CyP were iden- 
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tificd. In order to obtain the sequence-specific assign- amides of the Phe residues were easily identified in the 
merits, however, it was important o identify the amino HSQC spectrum (Fig. 3A), and from the ‘sN/‘3C cou- 
acid spin systems by amino acid type. Since this was pling observed for the unique L24-F25 dipeptide se- 
difficult to accomplish in the conventional manner from quence (inset), the amide of F25 was assigned. For “N- 
‘H.‘H scalar correlation experiments. we resorted to labeling of Gly and Lys, a prototrophic strain (AG-1) 
selective labeling of the individual amino acids (27,281. was employed as the host strain. Although scrambling 
nor labeling the Phe, Ile. Val, and Ala residues, a po- of the label occurred when “N-labeled Gly was part of 
lyauxotrophic strain, DL-39 [13], containing pBS12 was the culture medium, the additional labeling of the Ser 
employed to prevent the scrambling of the label. As 
for [“N-Phe,‘%Z=O-Leu]CyP/CsA, 
and Cys residues of CyP was useful for identifying the 
illustrated the amides of these amino acids (Fig. 3B). 
Table I. ‘H, 13C, and “N backbone chemical shifts of CyP when bound to CsA 
(~1.3 mM) measured at 20°C in phosphate buffer (50 mM, pH=6.5), containing 
NaCl (100mM) and dithiothreitol (5mM). 
Res. HN 
Ml - 
v2 
N3 
P4 - 
T5 8.79 
V6 8.72 
F7 8.96 
F8 9.54 
D9 9.27 
110 9.06 
All 9.65 
v12 8.93 
D13 9.87 
G14 8.58 
El5 8.06 
P16 - 
L17 9.19 
G18 7.24 
R19 8.39 
v20 9.39 
s21 8.78 
F22 9.49 
E23 8.71 
L24 8.16 
F25* 8.91 
A26 8.47 
D27 8.97 
K28 7.54 
v29 8.36 
P30 - 
15N C’ C" Ha 
174.5 56.9 
114.4 174.8 60.4 
120.0 173.1 58.5 
118.9 172.0 54.9 
117.0 174.4 53.0 
123.7 176.6 54.4 
123.7 175.4 57.7 
131.9 174.2 50.5 
117.8 175.9 60.1 
130.4 175.2 54.5 
101.1 173.1 45.0 
122.9 52.5 
175.4 64.4 
125.6 175.3 55.2 
101.6 169.4 44.9 
120.4 174.4 54.7 
126.3 173.2 59.6 
120.0 173.1 55.1 
118.5 174.8 55.4 
122.6 174.0 54.7 
121.9 176.5 51.4 
124.1 175.9 54.3 
128.5 175.6 54.1 
112.9 176.3 54.9 
117.4 176.2 56.2 
114.4 57.9 
180.2 65.9 
5.71 
5.31 
5.88 
5.32 
5.52 
5.20 
5.15 
4.50 
4.32 
4.19,3.41 
4.78 
4.70 
4.21,3.95 
5.63 
4.58 
5.53 
5.21 
4.70 
4.71 
5.13 
3.75 
4.27 
4.56 
4.41 
RCS. 
K311 
T32 
A33f 
E34 
N35 
F36 
R37 
A38 
L39 
s40 
T41 
G42 
E43 
K44 
G45 
F46 
G47 
Y48 
K49 
G50 
s51 
C52% 
F53 
H54 
R55+ 
156+ 
157+ 
P58 
G59+ 
F60+ 
HN 
10.71 
10.28 
9.23 
8.03 
7.13 
7.02 
8.96 
8.67 
8.22 
7.91 
7.99 
7.58 
8.00 
9.13 
7.94 
6.42 
7.74 
6.86 
8.47 
9.52 
8.41 
9.96 
8.68 
7.49 
6.89 
9.15 
8.49 
- 
9.83 
8.11 
15N C’ CQ 
123.3 181.0 60.1 
123.7 177.0 66.9 
124.8 177.4 55.6 
117.4 176.7 57.6 
115.2 174.0 56.4 
116.6 178.1 61.1 
120.4 177.3 60.1 
118.5 181.7 53.9 
120.4 178.8 56.9 
118.9 173.8 62.2 
107.7 177.5 62.6 
107.7 177.0 45.4 
117.8 175.8 58.2 
117.8 175.9 53.9 
104.8 171.9 44.3 
113.3 172.1 53.7 
104.0 170.9 45.2 
113.3 177.3 57.1 
124.5 176.8 60.8 
116.7 173.7 44.9 
116.3 171.1 58.7 
114.4 175.6 55.6 
122.6 174.4 57.7 
118.8 174.8 57.0 
123.7 172.5 54.6 
126.7 173.1 61.2 
126.7 57.2 
177.0 62.5 
113.7 171.5 44.8 
118.9 172.0 56.1 
HQ 
4.00 
3.98 
4.03 
4.49 
4.03 
4.11 
4.04 
3.75 
4.44 
4.27 
3.87,3.46 
4.28 
4.28,3.55 
4.60 
4.34,2.50 
4.20 
4.80,4.41 
4.63 
5.94 
4.87 
4.66 
5.09 
4.60 
5.28 
4.04 
5.19 
Table la 
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With the information obtained from selective labeling 
and the known primary sequence of CyP, the amides 
corresponding to the previously identified strings of ad- 
jacent amino acid residues were assigned. From the 
amide assignments, the carbonyl carbons were assigned 
by correlating the ‘H(wJ and ‘“N(w,) amide chemical 
shifts of CyP to the carbonyl “C frcquencics (w2) in a 
3D HNCO [22] experiment. 
The ‘H, ‘“C and 15N backbone assignments of CyP 
when bound to CsA are given in Table I. These back- 
bone assignments arc important for assigning the ‘H 
and 13C resonances of the CyP side chains [29 311 and 
are critical for interpreting heteronuclear 3D [24] and 
4D NOE [32-341 data sets used in the three-dimensional 
structure determination of the CyP/CsA complex (in 
progress). The current NMR data were analyzed in 
terms of the secondary structure of CyP when bound to 
Res. RN 15N C’ C” 
M61+ 7.85 109.6 173.7 54.3 
C62+ 8.32 112.6 172.2 57.3 
Q63’ 9.33 127.1 173.5 54.3 
G64+ 7.47 110.0 172.2 44.5 
G65* 9.11 104.8 174.8 46.4 
D66+ 9.99 123.7 175.8 51.2 
F67+ 6.73 115.5 173.5 55.8 
T68 7.25 108.1 175.1 61.4 
R69 8.70 121.5 175.6 54.6 
H70’ 6.58 110.7 173.6 56.8 
N71+ 7.44 111.8 175.1 52.1 
G72* 9.66 110.7 174.5 44.8 
T73+ 7.87 109.2 175.6 61.9 
G74+ 8.80 113.3 174.5 44.8 
G75 8.09 108.5 171.5 42.9 
K76 6.95 115.2 171.8 55.6 
s77 7.79 114.1 175.1 56.7 
178 8.57 110.3 175.5 63.3 
Y79 8.08 120.4 174.8 56.0 
G80 7.12 105.9 173.4 42.7 
E81 8.97 122.6 175.2 60.2 
K82 7.89 112.2 174.8 53.5 
F83 9.20 115.9 172.9 55.6 
E84 9.25 118.9 175.6 56.2 
D85 8.66 118.5 175.5 54.2 
E86 9.56 131.5 175.6 60.0 
N87 7.07 106.3 170.0 52.4 
F88+ 8.33 112.2 177.0 55.5 
189 8.31 119.3 177.0 64.6 
L90 7.79 117.0 175.6 53.7 
Ha 
5.15 
4.81 
5.13 
4.25 
4.61 
4.62 
4.38 
4.42 
4.51 
4.47 
4.15 
4.46,3.45 
4.57,2.64 
4.66 
5.21 
4.20 
4.66 
4.65,3.80 
4.49 
5.54 
4.96 
3.78 
4.28 
4.12 
5.96 
3.74 
4.45 
CsA. Based on the NOE data obtained from the 15N- 
resolved 3D NOESY-HSQC spectra, the secondary 
structure of CyP when bound to CsA was found to 
consist of an antiparallel /3-sheet composed of 8 strands 
and 2 a-helices, similar to that determined previously by 
Wuthrich and coworkers [I I] for uncomplexed CyP. 
As indicated in Table 1 and Fig. 3C. several CyP 
amides shift upon binding CsA. Thcsc changes in chem- 
ical shift mainly occur in four regions of Cyp. These 
include CyP residues 55- 74, 9X 104, 1 12 .116 and 12% 
126. Wtithrich and co-workers [ 101 reported similar 
shifts of CyP signals upon binding a water-soluble CsA 
derivative to CyP. Although these regions are far apart 
in the primary structure of CyP, the NOE data indicates 
that they are relatively close to one another in space 
(Fig. 4). On the basis of chemical shift differences be- 
tween uncomplcxed CyP and CyP bound to CsA or a 
Res. IIN 15N Cl -cl c II” 
K91 8.09 118.5 175.6 54.1 4.60 
1192+ 10.58 121.9 177.0 56.3 4.34 
T93 7.24 109.6 174.8 62.9 4.00 
G94+ 7.54 106.6 45.3 4.75,4.44 
P95 - 176.4 62.4 
G96r 9.24 110.3 172.5 44.7 4.60,3.35 
197 6.78 120.7 172.1 59.2 4.02 
L98’ 7.82 129.3 173.0 53.0 4.81 
S99+ 7.96 118.9 173.4 54.1 5.21 
MlOO+ 8.29 122.6 178.4 53.5 5.51 
AlOl+ 8.23 126.3 174.5 51.4 4.72 
N102+ 7.70 113.3 172.3 53.4 4.71 
A 103+ 9.26 120.7 175.9 50.1 4.73 
G104’ 8.24 107.7 43.1 4.68,3.72 
P105 - 175.5 63.7 
NlO6 8.86 118.9 174.4 54.0 4.11 
T107+ 10.31 110.0 172.9 59.9 4.44 
N108 7.43 120.0 173.4 55.5 4.20 
G109 9.15 110.3 170.4 45.5 4.62 
SllO 8.77 116.7 175.3 57.1 4.78 
Qlll 8.42 124.5 175.5 57.9 4.29 
F112+ 8.17 117.0 171.4 55.0 6.05 
F113+ 9.83 114.4 172.1 54.7 5.s5 
1114’ 9.03 117.0 176.7 58.7 4.86 
C115’ 9.50 124.1 175.9 61.1 4.58 
T116t 9.05 115.2 171.9 GO.3 4.40 
All7 7.62 121.9 174.5 50.4 4.37 
K118 8.73 119.3 175.G 57.3 3.79 
T119 7.38 117.4 174.5 56.7 3.55 
E120i 9.09 124.1 176.8 59.0 5.19 
Table Ib 
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water soluble CsA derivative [lo], the CyP binding site 
for CsA can be infcrrcd. However, changes in CyP 
chemical shifts may arise from either a direct interaction 
between CsA and CyP or a conformational change in 
the protein distant from the CsA binding site. Further- 
more, the CyP chemical shift data cannot be used to 
determine the orientation of CsA in the CyP binding 
pocket. Further structural characterization of the CsA 
binding site was obtained from an analysis of CyP/CsA 
NOES which were previously observed in “C-resolved 
3D HMQC-NOESY spectra of uniformly l’C-labcled 
CsA bound to CyP [9]. Using the NMR data obtained 
in this study, some of the previously obscrvcd intermo- 
lecular NOES could now be assigned. These include: 
Al01 (H”)/Abu’(H’), AIOl(HB)IAbu’(HY), AIOI(H”)/ 
Res. HN 15N C’ C” 
W121’ 7.31 117.8 175.5 59.7 
L122t 7.06 120.4 176.5 54.0 
D123t 7.59 121.9 177.5 55.4 
G1241 9.58 110.7 171.5 44.7 
K125’ 7.59 114.1 174.4 55.9 
H126t 7.44 120.0 173.2 54.7 
V127 8.25 124.1 174.1 63.4 
V128 9.45 132.6 174.4 62.9 
F129 8.12 116.7 172.1 55.6 
G130 7.37 110.0 170.1 46.2 
K131 8.30 114.4 174.4 54.5 
V132 9.01 123.3 174.8 63.7 
K133 9.45 131.1 174.8 56.4 
El34 7.54 117.7 174.3 55.0 
G135 8.70 107.4 176.5 46.1 
Ml36 8.88 122.9 177.0 56.5 
N137 8.92 113.7 176.8 55.7 
1138 7.65 123.7 177.0 61.1 
V139 7.28 121.5 177.4 65.7 
El40 8.31 117.4 178.7 58.9 
A141 7.51 120.7 179.9 54.5 
Ml42 8.31 116.6 177.2 59.3 
El43 7.89 115.9 177.3 58.7 
H” 
4.72 
4.32 
5.18 
4.06 
4.80 
4.24 
3.98 
5.24 
3.08 
5.16 
4.42 
4.55 
4.80,3.97 
4.46 
4.44 
3.75 
3.86 
4.67 
4.09 
3.96 
3.74 
McVal”(HY’), FGO( H”)/MeVal ’ ‘( Hy’), F60( Ho/ 
MeVal”(HY’), F6O(H”)lMeLeu”(H”‘), and F60(H’)/ 
MeLeu’O(NCH,). As shown in Fig. 4, these NOES to- 
gether with CyP/CsA NOES assigned previously be- 
tween MeLeu’(HS) of CsA and the sidechain of W121 
[35] can be used to orient CsA in the CyP binding site. 
Further characterization of the 3D structure of the CyP/ 
CsA complex is in progress from an analysis of hetero- 
nuclear 3D [24] and 4D NOE [32-341 data which can be 
interpreted using the ‘H, “N, and 13C assignments ob- 
tained in this study combined with those obtained from 
“C-‘“C coherence transfer experiments [29-311. 
A~krro~~,/~,cl~er,~~~~~,~~ P. Neri acknowledges support from a fellowship 
from the CNR, Italy (Hando 20.X03.22. Corn. Scicnzc Chimiche). 
Res. HN 15N C’ CQ 
R144 7.01 114.1 176.6 57.3 
F145 7.63 114.8 175.2 57.7 
G146 7.57 104.4 171.2 43.7 
s147 8.21 109.2 174.8 57.8 
R148 8.93 120.0 176.2 59.4 
N149 7.87 110.7 176.2 52.1 
G150 8.07 110.3 172.7 44.6 
K151 7.56 119.3 178.0 56.8 
T152 8.88 116.7 175.4 59.5 
s153 9.47 117.4 174.0 58.7 
K154 7.54 118.5 173.8 54.3 
K155 8.80 121.1 175.5 56.2 
1156 9.63 133.7 175.8 58.8 
T157 9.23 117.0 173.0 59.1 
1158 8.58 121.1 174.0 60.5 
Al59 8.86 131.9 177.9 53.9 
D160 8.06 110.7 172.2 52.4 
Cl61 8.59 115.5 171.9 55.0 
G162 6.85 104.0 169.6 45.1 
Q163 9.09 120.4 174.8 54.8 
L164 8.59 125.6 175.5 54.5 
El65 8.15 125.6 57.8 
HO 
3.92 
4.79 
4.59,3.61 
4.80 
4.83 
4.17,4.00 
4.40 
5.57 @ 
4.42 
4.53 
4.30 
5.08 
5.30 
4.22 
4.12 
4.87 
4.53 
3.51 
5.05 
4.62 
4,15 
* ‘H and t3C chemical shifts 
NH415N0a (376.25 ppm)[36J. 
are reported relative to TSP. 15N chemical shifts are referenced to 
t Amide cross-peaks observed in the HSQC spectrum of [U-“N]CyP/CsA that do not match any 
of the cross-peaks in the HSQC spectrum of uncomplexed CyP within the range of f 0.7 ppm for 
15N and/or & 0.17 ppm for ‘H. 
$ AS for (t) but within the range off 6.2-6.7 ppm for 15N and/or & 0.08-0.17 ppm for ‘H. 
Table Ic 
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